
QIAGEN N.V. QGEN
Annual report 2025
added 04-18-2026
QIAGEN N.V. Operating Cycle 2011-2026 | QGEN
Annual Operating Cycle QIAGEN N.V.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 172 | 207 | 205 | 199 | 186 | 190 | 203 | 187 | 190 | 204 | 193 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 207 | 172 | 194 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | ||
|
Agilent Technologies
A
|
161 | $ 115.9 | 0.73 % | $ 35.2 B | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
1.79 K | $ 7.59 | -16.68 % | $ 10.1 M | ||
|
Castle Biosciences
CSTL
|
97.4 | $ 20.94 | 6.35 % | $ 607 M | ||
|
Aspira Women's Health
AWH
|
1.2 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | ||
|
Fulgent Genetics
FLGT
|
87 | $ 17.68 | 0.03 % | $ 544 M | ||
|
Guardant Health
GH
|
128 | $ 125.25 | 4.51 % | $ 15.7 B | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 22.05 | 2.37 % | $ 1.17 B | ||
|
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | ||
|
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | ||
|
Interpace Biosciences
IDXG
|
96 | $ 1.8 | - | $ 7.96 M | ||
|
ICON Public Limited Company
ICLR
|
70.3 | $ 117.6 | 3.29 % | $ 9.7 B | ||
|
Illumina
ILMN
|
198 | $ 151.1 | 4.05 % | $ 24 B | ||
|
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | ||
|
Lantheus Holdings
LNTH
|
121 | $ 99.53 | -0.53 % | $ 6.72 B | ||
|
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 093.48 | -0.71 % | $ 22.5 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 163.66 | 4.54 % | $ 8.11 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | ||
|
NeoGenomics
NEO
|
102 | $ 9.52 | 2.7 % | $ 1.22 B | ||
|
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 430.27 | 0.27 % | $ 12.4 B | ||
|
National Research Corporation
NRC
|
29.4 | $ 19.04 | - | $ 426 M | ||
|
Natera
NTRA
|
81.5 | $ 203.17 | 1.12 % | $ 20 B | ||
|
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
95.1 | $ 3.91 | 1.56 % | $ 362 M | ||
|
Personalis
PSNL
|
63.8 | $ 9.35 | 4.53 % | $ 834 M | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 26.55 | -1.5 % | $ 25.2 B | ||
|
Senseonics Holdings
SENS
|
104 | $ 6.27 | -2.49 % | $ 262 M | ||
|
Soleno Therapeutics
SLNO
|
1.04 K | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
204 | $ 2.38 | -3.64 % | $ 5.47 M | ||
|
Twist Bioscience Corporation
TWST
|
96.1 | $ 64.96 | 0.14 % | $ 3.89 B | ||
|
Laboratory Corporation of America Holdings
LH
|
71.8 | $ 259.0 | 0.23 % | $ 21.5 B | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 452.36 | 0.92 % | $ 171 B | ||
|
Waters Corporation
WAT
|
834 | $ 343.25 | 1.35 % | $ 20.4 B | ||
|
Trinity Biotech plc
TRIB
|
299 | $ 0.67 | 3.54 % | $ 241 M | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
213 | $ 9.27 | 1.42 % | $ 2.01 B | ||
|
Quest Diagnostics Incorporated
DGX
|
54.2 | $ 194.63 | 0.89 % | $ 21.6 B |